array(40) {
  [0]=>
  string(4) "2111"
  ["article_id"]=>
  string(4) "2111"
  [1]=>
  string(66) "Former Juno Exec Stern Joins FogPharma as Chief Scientific Officer"
  ["article_title"]=>
  string(66) "Former Juno Exec Stern Joins FogPharma as Chief Scientific Officer"
  [2]=>
  string(152) "FogPharma has appointed Howard Stern to serve as its chief scientific officer. Before joining the Boston company, Stern was vice president of transla"
  ["short_description"]=>
  string(152) "FogPharma has appointed Howard Stern to serve as its chief scientific officer. Before joining the Boston company, Stern was vice president of transla"
  [3]=>
  string(405) "FogPharma has appointed Howard Stern to serve as its chief scientific officer. Before joining the Boston company, Stern was vice president of translational sciences at Juno Therapeutics, which was acquired by Celgene (NASDAQ: CELG) in 2015. Stern’s experience also includes posts at Infinity Pharmaceuticals and Genentech. In other moves, FogPharma named Peter Fekkes vice president of […]"
  ["description"]=>
  string(405) "FogPharma has appointed Howard Stern to serve as its chief scientific officer. Before joining the Boston company, Stern was vice president of translational sciences at Juno Therapeutics, which was acquired by Celgene (NASDAQ: CELG) in 2015. Stern’s experience also includes posts at Infinity Pharmaceuticals and Genentech. In other moves, FogPharma named Peter Fekkes vice president of […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(105) "https://xconomy.com/boston/2019/05/07/former-juno-exec-stern-joins-fogpharma-as-chief-scientific-officer/"
  ["blog_url"]=>
  string(105) "https://xconomy.com/boston/2019/05/07/former-juno-exec-stern-joins-fogpharma-as-chief-scientific-officer/"
  [15]=>
  string(19) "2019-05-08 00:32:05"
  ["add_date"]=>
  string(19) "2019-05-08 00:32:05"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2220"
  ["article_id"]=>
  string(4) "2220"
  [1]=>
  string(74) "Clarigent, Children’s Home partner on AI-based decision support app"
  ["article_title"]=>
  string(74) "Clarigent, Children’s Home partner on AI-based decision support app"
  [2]=>
  string(160) "Health application developer Clarigent Health is teaming up with The Children’s Home of Cincinnati to complete a pilot study using Clarigent’s art"
  ["short_description"]=>
  string(160) "Health application developer Clarigent Health is teaming up with The Children’s Home of Cincinnati to complete a pilot study using Clarigent’s art"
  [3]=>
  string(221) "Health application developer Clarigent Health is teaming up with The Children’s Home of Cincinnati to complete a pilot study using Clarigent’s artificial intelligence-powered mobile decision support app.&#nl"
  ["description"]=>
  string(221) "Health application developer Clarigent Health is teaming up with The Children’s Home of Cincinnati to complete a pilot study using Clarigent’s artificial intelligence-powered mobile decision support app.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(101) "https://www.healthcareitnews.com/news/clarigent-children-s-home-partner-ai-based-decision-support-app"
  ["blog_url"]=>
  string(101) "https://www.healthcareitnews.com/news/clarigent-children-s-home-partner-ai-based-decision-support-app"
  [15]=>
  string(19) "2019-05-08 00:21:19"
  ["add_date"]=>
  string(19) "2019-05-08 00:21:19"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:49"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2112"
  ["article_id"]=>
  string(4) "2112"
  [1]=>
  string(64) "Kyn Therapeutics Promotes Jeffrey Ecsedy, Jason Sager to C-Suite"
  ["article_title"]=>
  string(64) "Kyn Therapeutics Promotes Jeffrey Ecsedy, Jason Sager to C-Suite"
  [2]=>
  string(157) "Kyn Therapeutics has two new executives on its management team. Jeffrey Ecsedy, the Boston company’s senior vice president, R&D, was promoted t"
  ["short_description"]=>
  string(157) "Kyn Therapeutics has two new executives on its management team. Jeffrey Ecsedy, the Boston company’s senior vice president, R&D, was promoted t"
  [3]=>
  string(360) "Kyn Therapeutics has two new executives on its management team. Jeffrey Ecsedy, the Boston company’s senior vice president, R&D, was promoted to chief scientific officer. Also, Jason Sager is now chief medical officer after holding that post on an interim basis for the past two years. Kyn emerged in 2017 with $49 million in funding to […]"
  ["description"]=>
  string(360) "Kyn Therapeutics has two new executives on its management team. Jeffrey Ecsedy, the Boston company’s senior vice president, R&D, was promoted to chief scientific officer. Also, Jason Sager is now chief medical officer after holding that post on an interim basis for the past two years. Kyn emerged in 2017 with $49 million in funding to […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(102) "https://xconomy.com/boston/2019/05/07/kyn-therapeutics-promotes-jeffrey-ecsedy-jason-sager-to-c-suite/"
  ["blog_url"]=>
  string(102) "https://xconomy.com/boston/2019/05/07/kyn-therapeutics-promotes-jeffrey-ecsedy-jason-sager-to-c-suite/"
  [15]=>
  string(19) "2019-05-08 00:21:10"
  ["add_date"]=>
  string(19) "2019-05-08 00:21:10"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2194"
  ["article_id"]=>
  string(4) "2194"
  [1]=>
  string(37) "Frenova bolsters research site lineup"
  ["article_title"]=>
  string(37) "Frenova bolsters research site lineup"
  [2]=>
  string(132) "Frenova Renal Research is expanding its site network to accelerate clinical trial enrollment with the addition of more than 450 PIs."
  ["short_description"]=>
  string(132) "Frenova Renal Research is expanding its site network to accelerate clinical trial enrollment with the addition of more than 450 PIs."
  [3]=>
  string(132) "Frenova Renal Research is expanding its site network to accelerate clinical trial enrollment with the addition of more than 450 PIs."
  ["description"]=>
  string(132) "Frenova Renal Research is expanding its site network to accelerate clinical trial enrollment with the addition of more than 450 PIs."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(143) "https://www.outsourcing-pharma.com/Article/2019/05/07/Frenova-bolsters-research-site-lineup?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(143) "https://www.outsourcing-pharma.com/Article/2019/05/07/Frenova-bolsters-research-site-lineup?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-08 00:18:00"
  ["add_date"]=>
  string(19) "2019-05-08 00:18:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2077"
  ["article_id"]=>
  string(4) "2077"
  [1]=>
  string(75) "New treatment for severe dry eye disease promising in early clinical trials"
  ["article_title"]=>
  string(75) "New treatment for severe dry eye disease promising in early clinical trials"
  [2]=>
  string(150) "Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discom"
  ["short_description"]=>
  string(150) "Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discom"
  [3]=>
  string(184) "Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a new article. "
  ["description"]=>
  string(184) "Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a new article. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2019/05/190507121435.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2019/05/190507121435.htm"
  [15]=>
  string(19) "2019-05-08 00:14:35"
  ["add_date"]=>
  string(19) "2019-05-08 00:14:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:23"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:23"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2078"
  ["article_id"]=>
  string(4) "2078"
  [1]=>
  string(76) "Colorado nail salon workers face chronic air pollution, elevated cancer risk"
  ["article_title"]=>
  string(76) "Colorado nail salon workers face chronic air pollution, elevated cancer risk"
  [2]=>
  string(150) "Colorado nail salon employees face increased health risks due to high levels of indoor airborne pollutants such as formaldehyde and benzene, new resea"
  ["short_description"]=>
  string(150) "Colorado nail salon employees face increased health risks due to high levels of indoor airborne pollutants such as formaldehyde and benzene, new resea"
  [3]=>
  string(253) "Colorado nail salon employees face increased health risks due to high levels of indoor airborne pollutants such as formaldehyde and benzene, new research finds, concluding that working in a salon is akin to working at an oil refinery or an auto garage. "
  ["description"]=>
  string(253) "Colorado nail salon employees face increased health risks due to high levels of indoor airborne pollutants such as formaldehyde and benzene, new research finds, concluding that working in a salon is akin to working at an oil refinery or an auto garage. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2019/05/190507121416.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2019/05/190507121416.htm"
  [15]=>
  string(19) "2019-05-08 00:14:16"
  ["add_date"]=>
  string(19) "2019-05-08 00:14:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:23"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:23"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1883"
  ["article_id"]=>
  string(4) "1883"
  [1]=>
  string(55) "Shame Around Mental Illness May Be Fading, Survey Shows"
  ["article_title"]=>
  string(55) "Shame Around Mental Illness May Be Fading, Survey Shows"
  [2]=>
  string(153) "TUESDAY, May 7, 2019 -- Stigma regarding mental health could be disappearing in the United States, a new survey finds.&#nlIn the online poll of more than"
  ["short_description"]=>
  string(153) "TUESDAY, May 7, 2019 -- Stigma regarding mental health could be disappearing in the United States, a new survey finds.&#nlIn the online poll of more than"
  [3]=>
  string(252) "TUESDAY, May 7, 2019 -- Stigma regarding mental health could be disappearing in the United States, a new survey finds.&#nlIn the online poll of more than 1,000 adults, 87% said a mental disorder is nothing to be ashamed of, and 86% said they believe..."
  ["description"]=>
  string(252) "TUESDAY, May 7, 2019 -- Stigma regarding mental health could be disappearing in the United States, a new survey finds.&#nlIn the online poll of more than 1,000 adults, 87% said a mental disorder is nothing to be ashamed of, and 86% said they believe..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(190) "https://www.drugs.com/news/shame-around-mental-illness-may-fading-survey-shows-82319.html?utm_source=ddc&utm_medium=rss&utm_campaign=Shame+Around+Mental+Illness+May+Be+Fading%2C+Survey+Shows"
  ["blog_url"]=>
  string(190) "https://www.drugs.com/news/shame-around-mental-illness-may-fading-survey-shows-82319.html?utm_source=ddc&utm_medium=rss&utm_campaign=Shame+Around+Mental+Illness+May+Be+Fading%2C+Survey+Shows"
  [15]=>
  string(19) "2019-05-08 00:05:59"
  ["add_date"]=>
  string(19) "2019-05-08 00:05:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:49"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2150"
  ["article_id"]=>
  string(4) "2150"
  [1]=>
  string(61) "Less is more: Accumold talks ultra-thin walled micro moulding"
  ["article_title"]=>
  string(61) "Less is more: Accumold talks ultra-thin walled micro moulding"
  [2]=>
  string(150) "Aaron Johnson, vice president of marketing and customer strategy, Accumold discusses trends towards ultra-thin walled micro moulding, as well as elect"
  ["short_description"]=>
  string(150) "Aaron Johnson, vice president of marketing and customer strategy, Accumold discusses trends towards ultra-thin walled micro moulding, as well as elect"
  [3]=>
  string(196) "Aaron Johnson, vice president of marketing and customer strategy, Accumold discusses trends towards ultra-thin walled micro moulding, as well as electronics and their roles within medical devices."
  ["description"]=>
  string(196) "Aaron Johnson, vice president of marketing and customer strategy, Accumold discusses trends towards ultra-thin walled micro moulding, as well as electronics and their roles within medical devices."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(67) "https://www.medicalplasticsnews.com/mpn-north-america/less-is-more/"
  ["blog_url"]=>
  string(67) "https://www.medicalplasticsnews.com/mpn-north-america/less-is-more/"
  [15]=>
  string(19) "2019-05-08 00:05:08"
  ["add_date"]=>
  string(19) "2019-05-08 00:05:08"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:39"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2195"
  ["article_id"]=>
  string(4) "2195"
  [1]=>
  string(58) "WuXi adds US-based clinical research firm to CRO business "
  ["article_title"]=>
  string(58) "WuXi adds US-based clinical research firm to CRO business "
  [2]=>
  string(111) "WuXi AppTec acquires Pharmapace to bolster its biometrics and clinical development service offerings worldwide."
  ["short_description"]=>
  string(111) "WuXi AppTec acquires Pharmapace to bolster its biometrics and clinical development service offerings worldwide."
  [3]=>
  string(111) "WuXi AppTec acquires Pharmapace to bolster its biometrics and clinical development service offerings worldwide."
  ["description"]=>
  string(111) "WuXi AppTec acquires Pharmapace to bolster its biometrics and clinical development service offerings worldwide."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(136) "https://www.outsourcing-pharma.com/Article/2019/05/07/WuXi-AppTec-Aquires-Pharmapace?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(136) "https://www.outsourcing-pharma.com/Article/2019/05/07/WuXi-AppTec-Aquires-Pharmapace?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-08 00:04:00"
  ["add_date"]=>
  string(19) "2019-05-08 00:04:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2374"
  ["article_id"]=>
  string(4) "2374"
  [1]=>
  string(78) "Medical News Today: Alzheimer's: How light therapy could protect the brain"
  ["article_title"]=>
  string(78) "Medical News Today: Alzheimer's: How light therapy could protect the brain"
  [2]=>
  string(154) "A study uncovers the neuron and immune cell changes that explain why light therapy can reduce toxic brain proteins in mouse models of Alzheimer's dise"
  ["short_description"]=>
  string(154) "A study uncovers the neuron and immune cell changes that explain why light therapy can reduce toxic brain proteins in mouse models of Alzheimer's dise"
  [3]=>
  string(158) "A study uncovers the neuron and immune cell changes that explain why light therapy can reduce toxic brain proteins in mouse models of Alzheimer's disease."
  ["description"]=>
  string(158) "A study uncovers the neuron and immune cell changes that explain why light therapy can reduce toxic brain proteins in mouse models of Alzheimer's disease."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/325118.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/325118.php"
  [15]=>
  string(19) "2019-05-08 00:00:00"
  ["add_date"]=>
  string(19) "2019-05-08 00:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:19"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2221"
  ["article_id"]=>
  string(4) "2221"
  [1]=>
  string(101) "Clinicians at the Bowen Center give trust back to IT staff after new network infrastructure installed"
  ["article_title"]=>
  string(101) "Clinicians at the Bowen Center give trust back to IT staff after new network infrastructure installed"
  [2]=>
  string(150) "Poor networking was hindering growth at the health system. With new tech, the clinician satisfaction rate has soared to 95% and network uptime is up t"
  ["short_description"]=>
  string(150) "Poor networking was hindering growth at the health system. With new tech, the clinician satisfaction rate has soared to 95% and network uptime is up t"
  [3]=>
  string(160) "Poor networking was hindering growth at the health system. With new tech, the clinician satisfaction rate has soared to 95% and network uptime is up to 99%.&#nl"
  ["description"]=>
  string(160) "Poor networking was hindering growth at the health system. With new tech, the clinician satisfaction rate has soared to 95% and network uptime is up to 99%.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(129) "https://www.healthcareitnews.com/news/clinicians-bowen-center-give-trust-back-it-staff-after-new-network-infrastructure-installed"
  ["blog_url"]=>
  string(129) "https://www.healthcareitnews.com/news/clinicians-bowen-center-give-trust-back-it-staff-after-new-network-infrastructure-installed"
  [15]=>
  string(19) "2019-05-07 23:50:35"
  ["add_date"]=>
  string(19) "2019-05-07 23:50:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:49"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2196"
  ["article_id"]=>
  string(4) "2196"
  [1]=>
  string(70) "Janssen collaborates with French startup for AI-powered drug discovery"
  ["article_title"]=>
  string(70) "Janssen collaborates with French startup for AI-powered drug discovery"
  [2]=>
  string(126) "Janssen and Iktos Pharmaceuticals enter an agreement to bolster small molecule discovery using virtual drug design technology."
  ["short_description"]=>
  string(126) "Janssen and Iktos Pharmaceuticals enter an agreement to bolster small molecule discovery using virtual drug design technology."
  [3]=>
  string(126) "Janssen and Iktos Pharmaceuticals enter an agreement to bolster small molecule discovery using virtual drug design technology."
  ["description"]=>
  string(126) "Janssen and Iktos Pharmaceuticals enter an agreement to bolster small molecule discovery using virtual drug design technology."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(176) "https://www.outsourcing-pharma.com/Article/2019/05/07/Janssen-collaborates-with-French-startup-for-AI-powered-drug-discovery?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(176) "https://www.outsourcing-pharma.com/Article/2019/05/07/Janssen-collaborates-with-French-startup-for-AI-powered-drug-discovery?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-07 23:49:00"
  ["add_date"]=>
  string(19) "2019-05-07 23:49:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}